000 01897 a2200493 4500
005 20250517223124.0
264 0 _c20191031
008 201910s 0 0 eng d
022 _a1582-4934
024 7 _a10.1111/jcmm.13701
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aVageli, Dimitra P
245 0 0 _aCurcumin prevents the bile reflux-induced NF-κB-related mRNA oncogenic phenotype, in human hypopharyngeal cells.
_h[electronic resource]
260 _bJournal of cellular and molecular medicine
_c09 2018
300 _a4209-4220 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnticarcinogenic Agents
_xpharmacology
650 0 4 _aBile
_xchemistry
650 0 4 _aBile Acids and Salts
_xantagonists & inhibitors
650 0 4 _aCurcumin
_xpharmacology
650 0 4 _aEpithelial Cells
_xcytology
650 0 4 _aErbB Receptors
_xgenetics
650 0 4 _aGene Expression Regulation
650 0 4 _aHumans
650 0 4 _aHydrogen-Ion Concentration
650 0 4 _aHypopharynx
_xcytology
650 0 4 _aInterleukin-6
_xgenetics
650 0 4 _aNF-kappa B
_xantagonists & inhibitors
650 0 4 _aPhenotype
650 0 4 _aPrimary Cell Culture
650 0 4 _aProto-Oncogene Proteins c-bcl-2
_xgenetics
650 0 4 _aProto-Oncogene Proteins c-rel
_xgenetics
650 0 4 _aRNA, Messenger
_xantagonists & inhibitors
650 0 4 _aSTAT3 Transcription Factor
_xgenetics
650 0 4 _aSignal Transduction
650 0 4 _aTranscription Factor RelA
_xgenetics
650 0 4 _aTumor Necrosis Factor-alpha
_xgenetics
650 0 4 _aWnt-5a Protein
_xgenetics
700 1 _aDoukas, Sotirios G
700 1 _aSpock, Todd
700 1 _aSasaki, Clarence T
773 0 _tJournal of cellular and molecular medicine
_gvol. 22
_gno. 9
_gp. 4209-4220
856 4 0 _uhttps://doi.org/10.1111/jcmm.13701
_zAvailable from publisher's website
999 _c28538923
_d28538923